Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains

被引:19
|
作者
Hadi Alijanvand, Saeid [1 ]
Peduzzo, Alessia [2 ]
Buell, Alexander K. [2 ]
机构
[1] Natl Inst Genet Engn & Biotechnol, Inst Ind & Environm Biotechnol, Bioproc Engn Dept, Tehran, Iran
[2] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark
关键词
amyloid; secondary nucleation; α -synuclein; amyloid beta; proliferation;
D O I
10.3389/fmolb.2021.669994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid fibrils are ordered protein aggregates and a hallmark of many severe neurodegenerative diseases. Amyloid fibrils form through primary nucleation from monomeric protein, grow through monomer addition and proliferate through fragmentation or through the nucleation of new fibrils on the surface of existing fibrils (secondary nucleation). It is currently still unclear how amyloid fibrils initially form in the brain of affected individuals and how they are amplified. A given amyloid protein can sometimes form fibrils of different structure under different solution conditions in vitro, but often fibrils found in patients are highly homogeneous. These findings suggest that the processes that amplify amyloid fibrils in vivo can in some cases preserve the structural characteristics of the initial seed fibrils. It has been known for many years that fibril growth by monomer addition maintains the structure of the seed fibril, as the latter acts as a template that imposes its fold on the newly added monomer. However, for fibrils that are formed through secondary nucleation it was, until recently, not clear whether the structure of the seed fibril is preserved. Here we review the experimental evidence on this question that has emerged over the last years. The overall picture is that the fibril strain that forms through secondary nucleation is mostly defined by the solution conditions and intrinsic structural preferences, and not by the seed fibril strain.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Secondary nucleation in amyloid formation
    Linse, S.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S67 - S67
  • [22] Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth
    Gillam, J. E.
    MacPhee, C. E.
    JOURNAL OF PHYSICS-CONDENSED MATTER, 2013, 25 (37)
  • [23] Microsecond Simulations of Amyloid Beta Fibril Nucleation in Reverse Micelles
    Eskici, Gozde
    Axelsen, Paul
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 528A - 529A
  • [24] Observation of Secondary Nucleation on Specific Aβ 42 Fibril Type
    Jeong, Jae Sun
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 255A - 255A
  • [25] Evidence for a secondary pathway for fibril growth during amyloid fibril formation by tau
    Ramachandran, Gayathri
    Udgaonkar, Jayant B.
    FASEB JOURNAL, 2012, 26
  • [26] Sequence and structural determinants of amyloid fibril formation
    Bemporad, Francesco
    Calloni, Giulia
    Campioni, Silvia
    Plakoutsi, Georgia
    Taddei, Niccolo
    Chiti, Fabrizio
    ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (09) : 620 - 627
  • [27] Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth
    Song, Zhiyuan
    Tang, Huayuan
    Gatch, Adam
    Sun, Yunxiang
    Ding, Feng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 279
  • [28] Molecular mechanisms of Aβ fibril elongation, secondary nucleation, and fibril dissociation studied in-silico
    Dorosh, Lyudmyla
    Stepanova, Maria
    PRION, 2019, 13 : 82 - 83
  • [29] Phosphatidylnositol and inositol, possible nucleation seeds for amyloid fibril growth.
    McLaurin, J
    Fraser, PE
    Franklin, T
    Chakrabartty, A
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S46 - S46
  • [30] Effects of beta-protein mutations on amyloid fibril nucleation and elongation
    Teplow, DB
    Lomakin, A
    Benedek, GB
    Kirschner, DA
    Walsh, DM
    ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, 1997, : 311 - 319